SEARCH

SEARCH BY CITATION

References

  • 1
    Cameron McKenna and Andersen Consulting. Evaluation of the Operation of Community Procedures for the Authorisation of Medicinal Products. Brussels: European Commission Directorate-General Enterprise, 2001 http://pharmacos.eudra.org.
  • 2
    Manning R & Keith A. The economics of direct-to-consumer advertising of prescription drugs. Economic Realities in Health Care Policy, Pub. Pfizer, 2001; 2 : 39.
  • 3
    European Commission. MEMO/01/267. Reform of EU Pharmaceutical Legislation. Brussels: European Commission, 2001 http://pharmacos.eudra.org.
  • 4
    Health Action International Europe. Press release, 17/7/01: HAI Europe criticises EC move towards DTCA and call for evidence of health benefit. The Netherlands: Health Action International Europe, 2001.
  • 5
    Policy Report. Promotion of Prescription Drugs: Public Health or Private Profit?. London: Consumers’ Association, 2001.
  • 6
    Coulter A, Entwistle V, Gilbert D. Informing Patients: an Assessment of the Quality of Patient Information Materials. London: King’s Fund, 1998.